This content is machine translated Cutaneous T-cell lymphoma (CTCL) First targeted antibody approved for CTCL patients with MF or SS The approval of the anti-CCR4 antibody mogamulizumab provides patients with cutaneous T-cell lymphoma (CTCL) of the mycosis fungoides (MF) and Sézary syndrome (SS) subtypes with an effective non-chemotherapeutic intervention for…
View Post 6 min This content is machine translated Non-Hodgkin's Lymphoma Primary cutaneous lymphoma – Useful information for dermatologists Primary cutaneous lymphomas are a heterogeneous group of lymphoproliferative T-cell or B-cell neoplasms. Skin lymphomas are among the rare forms of skin cancer. Clinical inspection has an important role in…
View Post 10 min This content is machine translated Lymphomas The Sézary syndrome The nonspecific symptoms in the early stages lead to a significant diagnostic latency of these primary cutaneous T-cell lymphomas. Extracorporeal photopheresis and new targeted therapies are increasingly improving therapeutic success…
View Post 1 min This content is machine translated Mycosis fungoides PUVA treatment shows lasting effect That a low-dose therapy consisting of psoralen and UV-A irradiation (PUVA) not only leads to a short-term remission of the cutaneous lymphoma “Mycosis fungoides”, but also maintains this remission for…
View Post 8 min This content is machine translated Neoplastic diseases Treatment and prognosis of cutaneous lymphoma Cutaneous lymphomas are a heterogeneous group of neoplastic diseases arising from clonal proliferation of lymphocytes in the skin. Overall, cutaneous lymphomas are rare skin cancers, with a prevalence of 1:100,000…
